Perioperative Immunization for Splenectomy and the Surgeon's Responsibility A Review

被引:29
作者
Casciani, Fabio [1 ]
Trudeau, Maxwell T. [1 ]
Vollmer, Charles M., Jr. [1 ]
机构
[1] Univ Penn, Dept Surg, Perelman Sch Med, 3400 Spruce St, Philadelphia, PA 19104 USA
关键词
23-VALENT PNEUMOCOCCAL POLYSACCHARIDE; OVERWHELMING POSTSPLENECTOMY INFECTION; INFLUENZAE TYPE-B; CONJUGATE VACCINE; ANTIBODY-RESPONSE; IMMUNE-RESPONSES; STREPTOCOCCUS-PNEUMONIAE; ASPLENIC INDIVIDUALS; BOOSTER VACCINATION; THALASSEMIA MAJOR;
D O I
10.1001/jamasurg.2020.1463
中图分类号
R61 [外科手术学];
学科分类号
摘要
This narrative review provides information on infectious disease risk in patients who have undergone splenectomy and discusses infection prevention with a variety of vaccination strategies, including perioperative vaccination by surgeons. Importance Patients who have had splenectomy have a lifelong risk of overwhelming postsplenectomy infection (OPSI), a condition associated with high mortality rates. Surgeons must be aware of the rationale of vaccination in the case of splenectomy, to provide appropriate immunization in the perioperative time. Observations English-language articles published from January 1, 1990, to December 31, 2019, were retrieved from MEDLINE/PubMed, Cochrane Library, and ClinicalTrials.gov databases. Randomized clinical trials as well as systematic reviews and observational studies were considered. Asplenia yields an impairment of both innate and adaptive immunity, thus increasing the risk of severe encapsulated bacterial infections. Current epidemiology of OPSI ranges from 0.1% to 8.5% but is hard to ascertain because of ongoing shifts in patients' baseline conditions and vaccine penetration. Despite the lack of randomized clinical trials, immunization appears to be effective in reducing OPSI incidence. Unfortunately, vaccination coverage is still suboptimal, with a great variability in vaccination rates being reported across institutions and time frames. Notably, current guidelines do not advocate any particular health care qualification responsible for vaccine prescription or administration. Given the dearth of high-level basic science or clinical evidence, the optimal vaccination timing and the need for booster doses are not yet well established. Although almost all guidelines indicate to not administer vaccines within 14 days before and after surgery, most data suggest that immunization might be effective even in the immediate perioperative time, thus placing the surgeon in a primary position for vaccine delivery. Furthermore, revaccination schedules are the target of ongoing debates, since a vaccine-driven hyporesponsiveness has been postulated. Conclusions and Relevance In patients who have undergone splenectomy, OPSI might be effectively prevented by proper immunization. Surgeons have the primary responsibility for achieving adequate, initial immunization in the setting of both planned and urgent splenectomy.
引用
收藏
页码:1068 / 1077
页数:10
相关论文
共 75 条
[1]   An opportunity for improvement in trauma care: 8-week booster vaccination adherence among patients after trauma splenectomy [J].
Alvarado, Aaron R. ;
Udobi, Kandi ;
Berry, Stepheny ;
Assmann, Jaynell ;
McDonald, Tracy ;
Winfield, Robert D. .
SURGERY, 2018, 163 (02) :415-418
[2]   Practical review of immunizations in adult patients with cancer [J].
Ariza-Heredia, Ella J. ;
Chemaly, Roy F. .
HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2015, 11 (11) :2606-2614
[3]   Impact of meningococcal vaccination on carriage and disease transmission: A review of the literature [J].
Balmer, Paul ;
Burman, Cynthia ;
Serra, Lidia ;
York, Laura J. .
HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2018, 14 (05) :1118-1130
[4]   The implications of immunization in the daily practice of pediatric anesthesia [J].
Bertolizio, Gianluca ;
Astuto, Marinella ;
Ingelmo, Pablo .
CURRENT OPINION IN ANESTHESIOLOGY, 2017, 30 (03) :368-375
[5]   Risk of infection and death among post-splenectomy patients [J].
Bisharat, N ;
Omari, H ;
Lavi, I ;
Raz, R .
JOURNAL OF INFECTION, 2001, 43 (03) :182-186
[6]   Influenza vaccines in immunosuppressed adults with cancer [J].
Bitterman, Roni ;
Eliakim-Raz, Noa ;
Vinograd, Inbal ;
Trestioreanu, Anca Zalmanovici ;
Leibovici, Leonard ;
Paul, Mical .
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2018, (02)
[7]   Adherence to vaccination guidelines post splenectomy: A five year follow up study [J].
Boam, Tristan ;
Sellars, Peter ;
Isherwood, John ;
Hollobone, Chloe ;
Pollard, Cristina ;
Lloyd, David M. ;
Dennison, Ashley R. ;
Garcea, Giuseppe .
JOURNAL OF INFECTION AND PUBLIC HEALTH, 2017, 10 (06) :803-808
[8]   Recommended vaccinations for asplenic and hyposplenic adult patients [J].
Bonanni, Paolo ;
Grazzini, Maddalena ;
Niccolai, Giuditta ;
Paolini, Diana ;
Varone, Ornella ;
Bartoloni, Alessandro ;
Bartalesi, Filippo ;
Santini, Maria Grazia ;
Baretti, Simonetta ;
Bonito, Carlo ;
Zini, Paola ;
Mechi, Maria Teresa ;
Niccolini, Fabrizio ;
Magistri, Lea ;
Pulci, Maria Beatrice ;
Boccalini, Sara ;
Bechinia, Angela .
HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2017, 13 (02) :359-368
[9]   Polysaccharide Conjugate Vaccine against Pneumococcal Pneumonia in Adults [J].
Bonten, M. J. M. ;
Huijts, S. M. ;
Bolkenbaas, M. ;
Webber, C. ;
Patterson, S. ;
Gault, S. ;
van Werkhoven, C. H. ;
van Deursen, A. M. M. ;
Sanders, E. A. M. ;
Verheij, T. J. M. ;
Patton, M. ;
McDonough, A. ;
Moradoghli-Haftvani, A. ;
Smith, H. ;
Mellelieu, T. ;
Pride, M. W. ;
Crowther, G. ;
Schmoele-Thoma, B. ;
Scott, D. A. ;
Jansen, K. U. ;
Lobatto, R. ;
Oosterman, B. ;
Visser, N. ;
Caspers, E. ;
Smorenburg, A. ;
Emini, E. A. ;
Gruber, W. C. ;
Grobbee, D. E. .
NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (12) :1114-1125
[10]   Hyporesponsiveness Following Booster Immunization With Bacterial Polysaccharides Is Caused by Apoptosis of Memory B Cells [J].
Brynjolfsson, Siggeir F. ;
Henneken, Maren ;
Bjarnarson, Stefania P. ;
Mori, Elena ;
Del Giudice, Giuseppe ;
Jonsdottir, Ingileif .
JOURNAL OF INFECTIOUS DISEASES, 2012, 205 (03) :422-430